Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
CERS · against 438 other Healthcare companies of similar size
Ranked #263 of 439 · scores higher than 39% of peers
Bars: peers in each 10-point band of the profitability score61 peers with a profitability score of 30–39, including CERS · Click a bar to see the companies
Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | CERS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 410 reported | -2.5% | 1.8% | 39% | 33% | |
| Operating marginHigher is better · 410 reported | -0.6% | 4.4% | 38% | 33% | |
| Return on assetsHigher is better · 435 reported | -3.3% | 0.9% | 35% | 33% | |
| Return on equityHigher is better · 414 reported | -10.8% | 0.7% | 35% | Context only | |
| Gross marginHigher is better · 456 reported | 52.0% | 39.6% | 63% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 914M USD | 99 | 81 | |
| 1 | 609M USD | 99 | 91 | |
| 258 | 471M NZD (≈$282M) | 35 | 23 | |
| 263 | 2.6B CNY (≈$359M) | 34 | 52 | |
| 263 | 3.2B CNY (≈$443M) | 34 | 27 | |
| 263 | 1.9B CNY (≈$264M) | 34 | 27 | |
| 263 | 472M USD | 34 | 33 | |
| 263 | 366M CHF (≈$421M) | 34 | 23 | |
| 263 | 20.5B INR (≈$246M) | 34 | 49 | |
| 269 | 5.9B CNY (≈$823M) | 33 | 20 | |
| 269 | 2.5B CNY (≈$349M) | 33 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score